Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Polycystic Ovary Syndrome 5Insulin Resistance 3Diabetes Mellitus, Type 2 3Urinary Bladder Neoplasms 2Pancreatic Neoplasms 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Diabetes Mellitus 2Carotid Intimal Medial Thickness 1 2Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene 1Skin Neoplasms 1Prostatic Neoplasms 1Pharmacokinetics of MDV3100 1Neoplasms 1Neoplasm Metastasis 1Meningioma 1Memory Disorders 1Liposarcoma, Myxoid 1Liposarcoma 1Leukoplakia, Oral 1Leukemia, Myeloid, Chronic-Phase 1Inflammation 1Head and Neck Neoplasms 1Glioblastoma 1Cognitive Dysfunction 1Carcinoma, Squamous Cell 1Brain Neoplasms 1Astrocytoma 1

Interventions

Gemcitabine 74Capecitabine 60Paclitaxel 59Fluorouracil 58Oxaliplatin 57Bevacizumab 51Docetaxel 50Leucovorin 48Nivolumab 40Cisplatin 40Irinotecan 39Carboplatin 37Cetuximab 34pembrolizumab 32Radiosurgery 32Trastuzumab 30Radiotherapy 27Everolimus 24Sorafenib 23Pemetrexed 20Doxorubicin 20Albumin-Bound Paclitaxel 20Ipilimumab 19Cyclophosphamide 19Panitumumab 18Zoledronic Acid 17Lapatinib 17Erlotinib Hydrochloride 17Prednisone 16pazopanib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasm Metastasis × Pioglitazone × Clear all
NCT02133625 2026-03-30

A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors

Dana-Farber Cancer Institute

Phase 1 Completed
14 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡